- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/54 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
Patent holdings for IPC class C07K 7/54
Total number of patents in this class: 329
10-year publication summary
|
15
|
16
|
19
|
22
|
15
|
21
|
29
|
14
|
23
|
32
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4824 |
15 |
| Chugai Seiyaku Kabushiki Kaisha | 1374 |
11 |
| Palatin Technologies, Inc. | 68 |
11 |
| Rhythm Pharmaceuticals, Inc. | 82 |
11 |
| Peptidream Inc. | 85 |
9 |
| University of South Florida | 1847 |
7 |
| Novacta Biosystems Limited | 18 |
7 |
| Bicyclerd Limited | 148 |
7 |
| Polyphor AG | 84 |
5 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 65 |
5 |
| Bicycletx Limited | 191 |
5 |
| Merck Sharp & Dohme LLC | 3732 |
5 |
| President and Fellows of Harvard College | 6030 |
4 |
| Aileron Therapeutics, Inc. | 80 |
4 |
| Ironwood Pharmaceuticals, Inc. | 162 |
4 |
| Napp Pharmaceutical Group Limited | 22 |
4 |
| Peptinov SAS | 20 |
4 |
| Protagonist Therapeutics, Inc. | 146 |
4 |
| The Texas a & M University System | 1771 |
4 |
| Fog Pharmaceuticals, Inc. | 11 |
4 |
| Other owners | 199 |